Impact of orotate phosphoribosyl transferase activity as a predictor of lymph node metastasis in gastric cancer

Oncology Reports

Volumn 14, Issue 4, 2005, Pages 987-992

  Ochiai, Takumi ^a   Sugitani, Michiharu ^a   Nishimura, Kazuhiko ^a   Noguchi, Hajime ^a   Okada, Tsuyoshi ^a   Ouchi, Masakazu ^a   Yamada, Masaki ^a   Kitajima, Masayuki ^a   Tsuruoka, Yuko ^a   Takahashi, Yuka ^a   Futagawa, Shunji ^a  

^a Tokyo Metropolitan Health and Medical Treatment Corporation   (Japan)

Author keywords

5 Fluorouracil; Gastric cancer; Lymph node metastasis; Orotate phosphoribosyl transferase

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; OROTATE PHOSPHORIBOSYLTRANSFERASE;

AGED; ARTICLE; CANCER INVASION; CELL PROLIFERATION; ECHOGRAPHY; ENZYMOLOGY; FEMALE; HUMAN; LYMPH NODE METASTASIS; MALE; METABOLISM; METASTASIS; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; STOMACH TUMOR;

AGED; ANTINEOPLASTIC AGENTS; CELL PROLIFERATION; FEMALE; FLUOROURACIL; HUMANS; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; OROTATE PHOSPHORIBOSYLTRANSFERASE; STOMACH NEOPLASMS; ULTRASONOGRAPHY;

EID: 33644829074     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.14.4.987     Document Type: Article

References (23)

1. Spiegelman S, Sawyer R, Nayak R, et al: Improving the antitumor activity of 5-fluorouracil by increasing its incorporation into RNA via metabolic modulation. Proc Natl Acad Sci USA 77: 4966-4970, 1980. (Pubitemid 11236547)
2. Cory JG, Breland IC and Carter GL: Effect of 5-fluorouracil on RNA metabolism Novikoff hepatoma cells. Cancer Res 39: 4905-4913, 1979. (Pubitemid 10167718)
3. Parker WB and Cheng YC: Metabolism and mechanism of action of 5-fluorouracil. Phamacol Ther 48: 381-395, 1990.
4. Danenberg PV: Thymidylate synthetase-a target enzyme in cancer chemotherapy. Biochim Biophys Acta 473: 73-92, 1977.
5. Shapiro JD, Harold N, Takimoto C, et al: A pilot study of interferon alpha-2a, fluorouracil, and leucovorin given with granulocyte-macrophage colony stimulating factor in advanced gastrointestinal adenocarcinoma. Clin Cancer Res 5: 2399-2408, 1999. (Pubitemid 29437319)
6. Salonga D, Danenderg KD, Johnson M, et al:. Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase and thymidine phosphorylase. Clin Cancer Res 6: 1322-1327, 2000. (Pubitemid 30226214)
7. Peters GJ, Braakhuis BJ, De Brujin EA, et al: Enhanced therapeutic efficacy of 5́deoxy-5-fluorouridine in 5-fluorouracil resistant head and neck tumors in relation to 5-fluorouracil metabolising enzymes. Br J Cancer 59: 327-334, 1989. (Pubitemid 19099991)
8. Naguib FN, Niedzwicki JG, Iltzsch MH, et al: Effects of N,N-dimethylformamide and sodium butyrate on enzymes of pyrimidine metabolism in cultured human tumor cells. Leuk Res 11: 855-861, 1987.
9. Ochiai T, Sugitani M, Nishimura K, et al: Correlation between 5-fluorouracil (5-FU) sensitivity as measured by collagen gel embedded culture drug sensitivity test (CD-DST) and expression of orotate phosphoribosyl transferase (OPRT), thymidylate synthase (TS) and dihydropyrimidine dehydrogenase (DPD) in colorectal cancer. Jpn J Cancer Chemother 28: 661-667, 2001.
10. Peters GJ, Laurensse E, Leyva A, et al: Sensitivity of human, murine and rat cells to 5-fluorouracil and 5́-deoxy-5-fluorouridine in relation to drug-metabolizing enzymes. Cancer Res 46: 20-28, 1986. (Pubitemid 16189022)
11. Inaba M, Mitsuhashi J, Sawada H, et al: Reduced activity of anabolizing enzymes in 5-fluorouracil-resistant human stomach cancer cells. Jpn J Cancer Res 87: 212-220, 1996. (Pubitemid 26099498)
12. Ichikawa W, Uetake H, Shirota Y, et al: Both gene expression for orotate phosphoribosyltransferase and its ratio to dihydropyrimidine dehydrogenase influence outcome following fluoro-pyrimidine-based chemotherapy for metastatic colorectal cancer. Br J Cancer 89: 1486-1492, 2003. (Pubitemid 37386604)
13. Fujii R, Seshimo A and Kameoka S: Relationships between the expression of thymidylate synthase, dihydropyrimidine dehydrogenase and orotate phosphoribosyltransferase and cell proliferative activity and 5-fluorouracil sensitivity in colorectal carcinoma. Int J Clin Oncol 8: 72-78, 2003. (Pubitemid 36548474)
14. Ichikawa W, Takahashi T, Nihei Z, et al: Polymorphisms of orotate phosphoribosyl transferase (OPRT) gene and thymidylate synthase tandem repeat (TSTR) predict adverse events (AE) in colorectal cancer (CRC) patients treated with 5-fluorouracil (FU) plus leucovorin (LV). Proc Am Soc Clin Oncol 22: 265, 2003.
15. Laskin JD, Evans RM, Slocum HK, et al: Basis for natural variation in sensitivity to 5-fluorouracil in mouse and human cells in culture. Cancer Res 39: 383-390, 1979. (Pubitemid 9095896)
16. Japanese Gastric Cancer Association: Japanese Classification of Gastric Carcinoma, 13th edition. Kanehara & Co., Ltd., Tokyo, 1999.
17. 2 statistics. Biometrics 38: 1011-1016, 1982.
18. 2 statistics for small samples. Biometrics 38: 1017-1023, 1982.
19. Mani NB, Suri S, Gupta S and Wig JD: Two-phase dynamic contrast-enhanced computed tomography with water-filling method for staging of gastric carcinoma. Clin Imaging 25: 38-43, 2001. (Pubitemid 32611551)
20. Kang BC, Kim JH, Kim KW, et al: Value of the dynamic and delayed MR sequence with Gd-DTPA in the T-staging of stomach cancer: correlation with the histopathology. Abdom Imaging 25: 14-24, 2000. (Pubitemid 30033440)
21. Perng DS, Jan CM, Wang WM, et al: Computed tomography, endoscopic ultrasonography and intraoperative assessment in TN staging of gastric carcinoma. J Formos Med Assoc 95: 378-385, 1996.
22. Kole AC, Plukker JT, Nieweg OE and Vaalburg W: Positron emission tomography for staging of oesophageal and gastroesophageal malignancy. Br J Cancer 78: 521-527, 1998. (Pubitemid 28360643)
23. Lerut T, Flarnen P, Ectors N, et al: Histopathologic validation of lymph node staging with FDG-PET scan in cancer of the esophagus and gastroesophageal junction: a prospective study based on primary surgery with extensive lymphadenectomy. Ann Surg 232: 743-752, 2000.